Awarded

C/ BASE NO CPA 2024_961 - INCLISIRAN 189 MG/ML SOL INJ SER 1.5 ML SC

Name: C/ BASE NO CPA 2024_961 - INCLISIRAN 189 MG/ML SOL INJ SER 1.5 ML SC
Creator: Unidade Local de Saúde de Coimbra, EPE
Published: 2026-09-15
License: https://ted.europa.eu/en/simap/legal-notice

Original language: Portuguese

Track this recordWith Adjudera Pro, get alerted before a contract here runs out.

Buyer: Unidade Local de Saúde de Coimbra, EPE
Winners: Novartis Farma, S.A.
Contract value: €407,848
Bids received: 1
Published: 15 Sept 2026
Awarded: 31 Aug 2026
Contract start: 31 Aug 2026
Contract end: 18 Sept 2027estimated
Sector: Medical equipment and pharmaceuticals
Region: Região de Coimbra
Source: Original notice on TED (639664-2026)

More awards from this buyer

Awarded	Buyer	Winner	Contract value	Published
Trastuzumab deruxtecano 100 mg Pó conc sol inj Fr IV	Unidade Local de Saúde de Coimbra, EPE	Daiichi Sankyo Portugal Unipessoal, Lda.	€1,209,900	29 Oct 2026
RISDIPLAM 5 MG COMP	Unidade Local de Saúde de Coimbra, EPE	ROCHE FARMACÊUTICA QUÍMICA, LDA.	€741,405	27 Oct 2026
Tafasitamab 200 mg Pó conc sol inj Fr IV	Unidade Local de Saúde de Coimbra, EPE	Cencora 3PL Portugal, S.A.	€126,324	26 Oct 2026
Pemigatinib 13.5 mg Comp	Unidade Local de Saúde de Coimbra, EPE	Cencora 3PL Portugal, S.A.	€136,627	26 Oct 2026
Tocilizumab 20 mg/ml Sol inj Fr 4 ml IV	Unidade Local de Saúde de Coimbra, EPE	ROCHE FARMACÊUTICA QUÍMICA, LDA.	—	26 Oct 2026
Tocilizumab 162 mg/0.9 ml Sol inj Caneta 0.9 ml SC	Unidade Local de Saúde de Coimbra, EPE	ROCHE FARMACÊUTICA QUÍMICA, LDA.	€473,664	26 Oct 2026